Sphere Fluidics, a company developing single cell analysis systems, has opened a facility in Granta Park, Cambridgeshire, UK. Doubling overall capacity, the laboratories enable the team’s expansion, and the development of new products.
The new facilities accommodate recent hires to Sphere Fluidics’ commercial and leadership team, as well as preparing for further recruitment by the end of the year. The first phase of building has opened 7,000 sq ft of space and has been purpose built with equipment, including a demonstration lab to give customers the opportunity to see the company’s single cell analysis and monoclonality assurance systems at work. The second phase, due to complete by the end of the 2023, will expand the company’s footprint further to around 30,000 sq ft.
Granta Park is a life-science research park which spans over 120 acres of land. Designed and renovated by COEL, Sphere Fluidics’ new laboratories are in addition to offices at Babraham Research Campus, also in Cambridgeshire (UK). The Company also has a network of international distributors in Japan, France, China, Switzerland, Germany, Austria, Benelux, Australia, Scandinavia, Korea and USA.
Dr Frank F Craig, CEO, Sphere Fluidics, commented “We are on an exciting growth trajectory – this state-of-the-art site at Granta Park gives us another opportunity to attract new talent to our team, and continue our rapid expansion. With the first stage of building complete, we look forward to harnessing the space to encourage customer visits and sales and develop new products for our customers.”
Rob Treanor, director of operations, Sphere Fluidics, added “It is important that our scientific and commercial teams are provided with the very best environment to work, and with our new world-class facilities, we are proud to be able to offer this within one of the UK’s most prestigious science parks. We hope to have the entire UK workforce under one roof by the end of next year, as we continue to develop the business.”